Position in RXST
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$142,484
+$128,434 QoQ
Shares Held
29,561
+1196.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 151 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $49,649,548 across 86 Medical Devices names. RXST ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
144,198 | $13,084,526 | |
| 2 | SYK |
Stryker Corp
|
17,775 | $5,596,281 | |
| 3 | MDT |
Medtronic plc
|
60,057 | $4,698,259 | |
| 4 | TXG |
10x Genomics, Inc.
|
90,139 | $3,455,929 | |
| 5 | BSX |
Boston Scientific Corp
|
77,337 | $3,300,743 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
34,980 | $3,011,428 | |
| 7 | BRKR |
Bruker Corp
|
49,085 | $2,953,935 | |
| 8 | PODD |
Insulet Corp
|
14,292 | $2,175,957 |
All Filings in RXST
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,484 | 29,561 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $14,050 | 2,281 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,596 | 729 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,633 | 3,185 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,393 | 261 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $631 | 25 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $790 | 23 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||